Observational studyFrontiers in endocrinology2026
Dapagliflozin associates with heart rate variability decline in T2DM patients on GLP-1 receptor agonist therapy: a prospective observational study.
Ying Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.